Shanghai Chicmax Cosmetics Co., Ltd. Class H (HK:2145)
:2145
Want to see HK:2145 full AI Analyst Report?
Top Page
Shanghai Chicmax Cosmetics Co., Ltd. Class H
(2145)
Select Model
Select Model
Rating:66Neutral
Price Target:
HK$51.00
▼(-26.51% Downside)
Action:ReiteratedDate:04/21/26
The score is primarily supported by strong financial performance (margin expansion, improved growth momentum, and conservative current leverage), but is held back by weak technicals (price well below key moving averages and negative MACD). Valuation is acceptable but not cheap given the ~24x P/E, with the ~2.9% dividend providing some support.
Positive Factors
Margin Expansion
Sustained gross and net margin expansion demonstrates durable pricing power and operating leverage in the core cosmetics business. Higher margins provide greater cash available for reinvestment, support higher ROE and cushion against cost shocks, improving long-term profitability resilience.
Negative Factors
Weaker Cash Conversion
Earnings have not fully translated into cash, indicating working capital or timing effects and limiting the durability of reported profits. Persistent subpar cash conversion constrains reinvestment, elevates sensitivity to cash-flow shocks, and can pressure dividends or debt servicing.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Expansion
Sustained gross and net margin expansion demonstrates durable pricing power and operating leverage in the core cosmetics business. Higher margins provide greater cash available for reinvestment, support higher ROE and cushion against cost shocks, improving long-term profitability resilience.
Read all positive factors
Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$19.56B
Dividend Yield2.53%
Average Volume (3M)662.88K
Price to Earnings (P/E)24.2
Beta (1Y)0.96
Revenue Growth35.28%
EPS Growth41.20%
CountryHK
Employees2,086
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)1.42
Shares Outstanding206,375,890
10 Day Avg. Volume806,967
30 Day Avg. Volume662,882
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)9.40
Price to Sales (P/S)2.91
P/FCF Ratio37.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$84.82Price Target Upside22.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)3.36
Revenue Forecast (FY)HK$11.09B
Shanghai Chicmax Cosmetics Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Shanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of skincare, and maternity and childcare products in China. The company offers a range of cosmetics, such as essence ...
How the Company Makes Money
null...
Shanghai Chicmax Cosmetics Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
82
Very Positive
Cash Flow
74
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.94B | 6.79B | 4.19B | 2.68B | 3.62B |
| Gross Profit | 6.83B | 5.11B | 2.99B | 1.70B | 2.36B |
| EBITDA | 1.24B | 752.09M | 676.04M | 268.88M | 404.70M |
| Net Income | 1.07B | 781.21M | 461.10M | 147.10M | 338.89M |
Balance Sheet | |||||
| Total Assets | 4.97B | 3.60B | 3.13B | 3.15B | 2.27B |
| Cash, Cash Equivalents and Short-Term Investments | 958.21M | 732.71M | 914.50M | 1.17B | 157.26M |
| Total Debt | 632.47M | 111.67M | 165.57M | 728.20M | 285.04M |
| Total Liabilities | 2.09B | 1.36B | 1.10B | 1.44B | 1.32B |
| Stockholders Equity | 2.77B | 2.19B | 2.01B | 1.71B | 949.98M |
Cash Flow | |||||
| Free Cash Flow | 690.54M | 304.38M | 657.69M | -23.51M | 269.46M |
| Operating Cash Flow | 1.21B | 546.95M | 746.16M | 36.56M | 335.19M |
| Investing Cash Flow | -448.86M | -187.03M | -457.49M | -66.78M | -55.29M |
| Financing Cash Flow | -404.82M | -595.67M | -737.21M | 1.03B | -289.56M |
Shanghai Chicmax Cosmetics Co., Ltd. Class H Technical Analysis
Negative
69.40
Price Trends
58.76
Negative
69.08
Negative
78.71
Negative
Market Momentum
-3.95
Positive
28.59
Positive
12.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2145, the sentiment is Negative. The current price of 69.4 is above the 20-day moving average (MA) of 53.55, above the 50-day MA of 58.76, and below the 200-day MA of 78.71, indicating a bearish trend. The MACD of -3.95 indicates Positive momentum. The RSI at 28.59 is Positive, neither overbought nor oversold. The STOCH value of 12.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2145.
Shanghai Chicmax Cosmetics Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$19.56B | 24.23 | 42.05% | 2.53% | 35.28% | 41.20% | |
66 Neutral | HK$32.83B | 16.77 | 19.93% | 1.84% | -0.47% | -11.39% | |
64 Neutral | HK$3.28B | 12.04 | 6.65% | 5.90% | 8.92% | 9.50% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$31.25B | 11.55 | 11.65% | 5.36% | 1.76% | 10.34% | |
51 Neutral | HK$18.52B | -43.19 | -4.30% | 5.00% | -1.71% | 53.04% | |
48 Neutral | HK$951.00M | 92.72 | -12.38% | ― | 52.36% | ― |
* Consumer Defensive Sector Average
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
48.32
-17.48
-26.57%
HK:1044
Hengan International Group Co
26.98
7.36
37.52%
HK:0157
Natural Beauty Bio-Technology
0.48
0.01
3.26%
HK:6601
Cheerwin Group Limited
2.47
0.30
13.62%
HK:2367
Giant Biogene Holding Co. Ltd.
29.40
-48.80
-62.40%
HK:6993
Blue Moon Group Holdings Ltd.
3.02
-0.66
-17.93%
Shanghai Chicmax Cosmetics Co., Ltd. Class H Corporate Events
Shanghai Chicmax Sets 2026 AGM to Approve 2025 Results, Dividend Plan and H-Share Buyback Mandate
Apr 16, 2026
Shanghai Chicmax Cosmetics Co., Ltd. has convened its annual general meeting for 8 May 2026 in Shanghai to review the board’s work report and the company’s 2025 annual report, and to approve a 2025 profit distribution plan. Shareholder...
Shanghai Chicmax Updates Final 2025 Dividend and Withholding Tax Arrangements
Apr 16, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has declared a final ordinary cash dividend of RMB 0.75 per share for the financial year ended 31 December 2025, subject to shareholder approval on 8 May 2026. The dividend will be paid on 23 June 2026 to shareh...
Shanghai Chicmax Updates Articles of Association After RSU-Linked H-Share Issuance
Apr 16, 2026
Shanghai Chicmax Cosmetic has updated its articles of association to reflect changes in its capital structure following the completion of an issue and allotment of 21,340 H shares under its restricted share unit scheme. After this issuance, the co...
Shanghai Chicmax Grants Fifth Round of Restricted Share Units to Key Employees
Mar 31, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has executed a fifth-round grant of restricted share units, issuing 25,519 RSUs to five Group employees, equivalent to about 0.01% of its outstanding share capital. The RSUs, priced at RMB1.00 per unit against a...
Shanghai Chicmax Profit Jumps 44% as KANS Brand Extends Lead in China Beauty Market
Mar 26, 2026
Shanghai Chicmax Cosmetic Co., Ltd. reported strong 2025 annual results, with revenue rising 35.1% year on year to RMB9.18 billion, gross profit up 37.3% to RMB7.01 billion, and profit climbing 43.7% to RMB1.15 billion, underpinned by robust deman...
Shanghai Chicmax Announces Final Cash Dividend for 2025
Mar 26, 2026
Shanghai Chicmax Cosmetic Co., Ltd., a Hong Kong-listed cosmetics company specializing in beauty and skincare products, has disclosed its board composition, which includes executive, employee representative and independent non-executive directors....
Shanghai Chicmax Teams With Suzhou Kintor to Commercialize New Whitening Ingredient KT-939
Mar 17, 2026
Shanghai Chicmax Cosmetic has entered into a strategic cooperation framework agreement with Suzhou Kintor Pharmaceutical to rapidly commercialize KT-939, a whitening and freckle-removing cosmetic ingredient, under an exclusivity arrangement in the...
Shanghai Chicmax Schedules Board Meeting to Approve 2025 Results and Consider Dividend, Share Buyback Mandate
Mar 16, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has scheduled a board meeting for March 26, 2026 to review and approve its annual results for the year ended December 31, 2025, and to decide on the publication of those results. The board will also consider rec...
Shanghai Chicmax Flags Sharp 2025 Profit and Revenue Growth on Skincare Brands
Mar 6, 2026
Shanghai Chicmax issued a positive profit alert, saying it expects 2025 revenue to rise about 34%–35% to roughly RMB9.1 billion–RMB9.2 billion, while profit is projected to climb about 42%–44% to RMB1.14 billion–RMB1.16 bil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.